PET/CT

Positron emission tomography/computed tomography is a hybrid nuclear medicine imaging technique that helps radiologists spot abnormal metabolic activity. PET/CT is commonly used to diagnose cancers, heart diseases and certain brain disorders, among other conditions.

Repurposed radiotracer lights up treatment-resistant tumors 'like a Christmas tree'
Use of the new tracer could improve outcomes by enabling providers to adjust treatment regimens much earlier than they have been able to previously.
Global shortage of nuclear imaging isotopes may be over
The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.
Researchers receive grant worth millions to develop portable PET scanner
Experts are hopeful that the portable scanner could improve access to neuroimaging used in the diagnosis and monitoring of Alzheimer's disease.
Understanding hospital billing for cardiac PET/CT
Significant fluctuations in PET and CT reimbursement rates have made it especially challenging to keep up with this complex topic. We spoke to an expert to learn more.
Lizard saliva could be key to spotting elusive pancreatic tumors
By binding the substance to a radiotracer, experts were able to improve the accuracy of identifying these tumors by as much as 30% compared to the standard of care.

3 indications auguring well for the future of pediatric PET/MRI

In pediatric care settings, hybrid PET/MR imaging combines “exquisite soft-tissue information obtained by MR imaging with functional information provided by PET.”

May 9, 2022

FDA clears spinal-tap test that could challenge PET in Alzheimer’s diagnostics

The FDA has approved a lab test for evaluating cognitively impaired adults who may be in the early stages of Alzheimer’s disease.

May 5, 2022

CMS coverage decision for Alzheimer's drug, related PET scans sparks concern in imaging community

In a statement released on April 14, MITA cautioned that the coverage decision will “severely limit patient access” to amyloid PET diagnostics and anti-amyloid monoclonal antibodies treatment.

April 18, 2022

coronavirus COVID-19 vaccine vaccination

FDG PET/CT radiomics distinguishes between vaccine-related or metastatic breast cancer lymphadenopathy

The findings could help clinicians manage patients’ treatment when the origin of axillary lymphadenopathy is of concern, experts suggested.

April 14, 2022

Combination therapy that includes new radionuclide proves effective for metastatic prostate cancer

The therapeutic combination of 177Lu-PSMA-617 with idronoxil (NOX66) reduced PSA levels in 86% of study participants.

April 8, 2022

MRI/PET scans link brainstem atrophy to dementia symptoms

Experts suggest that their findings could help differentiate between dementia and other neurological diseases that have similar symptoms.

April 7, 2022

New radiotracer that detects prostate cancer recurrence produces 'stunning' results

The research focused on a radiopharmaceutical that contains the isotope zirconium 89, which has a significantly longer half-life compared to gallium-68-labelled PSMA ligands.

March 29, 2022

PET scans spot brain abnormalities in long COVID patients

For 47% of patients with long COVID symptoms, brain PET scans identified mild to moderate or severe hypometabolic patterns.

March 29, 2022

PET/CT

Repurposed radiotracer lights up treatment-resistant tumors 'like a Christmas tree'

Global shortage of nuclear imaging isotopes may be over

Researchers receive grant worth millions to develop portable PET scanner

Understanding hospital billing for cardiac PET/CT

Lizard saliva could be key to spotting elusive pancreatic tumors